Da H. Lee - Publications

Probiotic-driven gut-liver redox crosstalk modulates hepatic Nrf2 signaling pathway and attenuates metabolic dysfunction-associated steatohepatitis.

Journal: Free radical biology & medicine

Published: February 10, 2026

PDE3B as a multi-organ therapeutic node in the gut-liver axis of metabolic dysfunction-associated steatohepatitis.

Journal: Experimental & molecular medicine

Published: June 19, 2025

Fecal microbiota transplantation improves hepatic fibro-inflammation via regulating oxidative stress in experimental NASH.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 07, 2023

Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model.

Journal: Gastroenterology report

Published: September 30, 2021

SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity.

Journal: Autophagy

Published: January 09, 2020

Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicity.

Journal: Autophagy

Published: March 26, 2019

Repositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity.

Journal: Free radical biology & medicine

Published: February 19, 2019

The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition.

Journal: Frontiers in endocrinology

Published: July 11, 2018

CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes.

Journal: PloS one

Published: June 18, 2018

Inactivation of Sirtuin2 protects mice from acetaminophen-induced liver injury: possible involvement of ER stress and S6K1 activation.

Journal: BMB reports

Published: April 17, 2018

p62/SQSTM1 is required for the protection against endoplasmic reticulum stress-induced apoptotic cell death.

Journal: Free radical research

Published: October 27, 2016

Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.

Journal: Free radical biology & medicine

Published: July 14, 2016